Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001450324-19-000028

Exec.Vice Chairman/CEO/Pres. acquired 17,960 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

EQUELS THOMAS K. · Exec.Vice Chairman/CEO/Pres.

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-12-13 Grant or award : show line 1 in the form +17,960 $0.44 $7,813 146,249 D
Loading xslF345X03/primary_doc.xml…